牋牋Serono is a global biotechnology leader with over 4,600 employees and worldwide revenues of USD 2.019 billion and a net income of USD 390 million in the year 2003.牋牋I(yíng)t has six recombinant products on the market and a strong pipeline with over 30 ongoing development projects, based both on proteins and small molecules.